Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Modelling the Evolution of Clonal Hematopoiesis to Myeloid Malignancies Under the Selective Pressure of Anti-Cancer Therapy

Christian Koch, Jonas Fullin, Ebru Topçu, Nancy Klemm, Karolina Zielinska, Monika Hebeisen, Joelle Tchinda, Markus G. Manz, Steffen Boettcher

Blood (2024) 144 (Supplement 1): 5651.

https://doi.org/10.1182/blood-2024-205797

Published: 2024

Journal Articles

The Pathogenesis of Therapy-Related Myeloid Neoplasms from TP53 -Mutant Clonal Hematopoiesis

Jonas Fullin, Ebru Topçu, Roman R. Schimmer, Nancy Klemm, Karolina Zielinska, Christian Koch, Francisco Caiado, Cyril Doerdelmann, Melissa Lock, Joelle Tchinda, Markus G. Manz, Massimo Lopes, Steffen Boettcher

Blood (2024) 144 (Supplement 1): 41.

https://doi.org/10.1182/blood-2024-205209

Published: 2024

Journal Articles

A New t(7;9)(p12;q34) Involving NOTCH1 and IKZF1 in Pediatric T-Cell Lymphoblastic Lymphoma

Frederic Paul Baleydier, Esther Amruthalingam, Marc Ansari, Anne-Laure Rougemont, David Hediger, Joelle Tchinda

Blood (2023) 142 (Supplement 1): 5734.

https://doi.org/10.1182/blood-2023-178542

Published: 2023

Journal Articles

Association of unbalanced translocation der(1;7) with germline GATA2 mutations

Blood (2021) 138 (23): 2441–2445.

https://doi.org/10.1182/blood.2021012781

Published: 2021

Includes: Supplemental data

Journal Articles

Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia

Blood (2017) 129 (11): e26–e37.

https://doi.org/10.1182/blood-2016-09-738070

Published: 2017

Includes: Supplemental data

Journal Articles

Somatic Genetic and Epigenetic Architecture of Myelodysplastic Syndromes Arising from GATA2 Deficiency

Victor Bengt Pastor Loyola, MSc, Shinsuke Hirabayashi, MD, Sandra Pohl, PhD, Emilia J Kozyra, MSc, Albert Catala, MD, Barbara De Moerloose, MD PhD, Michael Dworzak, MD, Henrik Hasle, MD, Riccardo Masetti, MD, Markus Schmugge, MD, Owen Smith, Jan Starý, MD, Marek Ussowicz, MD, Marry M. van den Heuvel-Eibrink, MD PhD, Ester Mejstrikova, MD PhD, Ulrich Salzer, MD, Michael Lübbert, MD, Daniel Heudobler, MD, David Betts, MD, Jose Cervera, MD, Gudrun Göhring, MD, Oskar A. Haas, Olga Haus, MD, Kyra Michalova, PhD DSc, Francesco Pasquali, MD, Joelle Tchinda, MD, Nadine van Roy, MD, Brigitte Schlegelberger, MD Prof., H. Berna Beverloo, PhD, Peter Noellke, MSc, Ayami Yoshimi, MD, Franco Locatelli, Prof, MD PhD, Brigitte Strahm, MD, Jaroslaw P. Maciejewski, MD PhD, Michael Rehli, PhD, Charlotte M Niemeyer, Prof, MD, Marcin W Wlodarski, MD

Blood (2015) 126 (23): 299.

https://doi.org/10.1182/blood.V126.23.299.299

Published: 2015

Journal Articles

Double hit, triple hit—look for it

Rudolf Benz, Joelle Tchinda

Blood (2013) 121 (13): 2383.

https://doi.org/10.1182/blood-2012-10-451716

Published: 2013

Journal Articles

Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment

Maike Schmitz, Petra Breithaupt, Nastassja Scheidegger, Gunnar Cario, Laura Bonapace, Barbara Meissner, Paulina Mirkowska, Joelle Tchinda, Felix K. Niggli, Martin Stanulla, Martin Schrappe, Andre Schrauder, Beat C. Bornhauser, Jean-Pierre Bourquin

Blood (2011) 118 (7): 1854–1864.

https://doi.org/10.1182/blood-2010-11-320309

Published: 2011

Includes: Supplemental data

Journal Articles

The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia

Pieter Van Vlierberghe, Martine van Grotel, Joëlle Tchinda, Charles Lee, H. Berna Beverloo, Peter J. van der Spek, Andrew Stubbs, Jan Cools, Kyosuke Nagata, Maarten Fornerod, Jessica Buijs-Gladdines, Martin Horstmann, Elisabeth R. van Wering, Jean Soulier, Rob Pieters, Jules P. P. Meijerink

Blood (2008) 111 (9): 4668–4680.

https://doi.org/10.1182/blood-2007-09-111872

Published: 2008

Includes: Supplemental data

Journal Articles

The Recurrent SET-NUP214 Fusion as a New HOXA Activation Mechanism in Pediatric T-Cell Acute Lymphoblastic Leukemia.

Pieter Van Vlierberghe, Joelle Tchinda, Martine van Grotel, Charles Lee, H. Berna Beverloo, Peter van der Spek, Andrew Stubbs, Jan Cools, Kyosuke Nagata, Maarten Fornerod, Jessica Buijs-Gladdines, Martine Horstmann, Elisabeth R. van Wering, Jean Soulier, Rob Pieters, Jules P.P. Meijerink

Blood (2007) 110 (11): 233.

https://doi.org/10.1182/blood.V110.11.233.233

Published: 2007

Journal Articles

Large Scale Copy Number Variation Upregulates the Expression of MYB in Human T-ALL.

Jennifer O’Neil, PhD, Joelle Tchinda, PhD, Alejandro Gutierrez, MD, Lisa Moreau, Keith McKenna, Richard Maser, PhD, Kwok-Kin Wong, MD, Wen-shu Wu, PhD, Ronald DePinho, MD, Lynda Chin, MD, Charles Lee, PhD, A. Thomas Look, MD

Blood (2006) 108 (11): 1408.

https://doi.org/10.1182/blood.V108.11.1408.1408

Published: 2006

Journal Articles

Changes in the Hierarchy of Risk Factors with Older Age in De-Novo Acute Myeloid Leukemia (AML).

Thomas Buchner, MD, Wolfgang E. Berdel, MD, Claudia Schoch, MD, Torsten Haferlach, MD, Hubert L. Serve, MD, Joachim Kienast, MD, Susanne Schnittger, PhD, Wolfgang Kern, MD, Joelle Tchinda, MD, Albrecht Reichle, MD, Peter Staib, MD, Wolf-Dieter Ludwig, MD, Carlo Aul, MD, Maria Cristina Sauerland, Dipl Math, Achim Heinecke, PhD, Bernhard Josef Wormann, MD, Wolfgang Hiddemann, MD

Blood (2006) 108 (11): 1977.

https://doi.org/10.1182/blood.V108.11.1977.1977

Published: 2006

Journal Articles

Intensification of Induction by High-Dose AraC and Outcome in Older Patients with De-Novo Acute Myeloid Leukemia (AML) and Subsets.

Thomas Buchner, MD, Wolfgang E. Berdel, MD, Claudia Schoch, MD, Torsten Haferlach, MD, Joelle Tchinda, MD, Susanne Schnittger, PhD, Wolfgang Kern, MD, Albrecht Reichle, MD, Peter Staib, MD, Hubert L. Serve, MD, Wolf-Dieter Ludwig, MD, Maria Cristina Sauerland, Dipl Math, Achim Heinecke, PhD, Bernhard Josef Wormann, MD, Wolfgang Hiddemann, MD

Blood (2006) 108 (11): 1978.

https://doi.org/10.1182/blood.V108.11.1978.1978

Published: 2006

Journal Articles

Double Induction Containing Two Courses Versus One Course of High- Dose AraC/ Mitoxantrone (HAM) and Autologous Stem Cell Transplantation Versus Prolonged Maintenance for Acute Myeloid Leukemia (AML).

Thomas Buchner, MD, Wolfgang E. Berdel, MD, Claudia Schoch, MD, Torsten Haferlach, MD, Hubert L. Serve, MD, Joachim Kienast, MD, Susanne Schnittger, PhD, Wolfgang Kern, MD, Joelle Tchinda, PhD, Albrecht Reichle, MD, Peter Staib, MD, Wolf-Dieter Ludwig, MD, Carlo Aul, MD, Maria-Cristina Sauerland, Achim Heinecke, PhD, Bernhard Woermann, MD, Wolfgang Hiddemann, MD

Blood (2005) 106 (11): 272.

https://doi.org/10.1182/blood.V106.11.272.272

Published: 2005

NARROW

Modelling the Evolution of Clonal Hematopoiesis to Myeloid Malignancies Under the Selective Pressure of Anti-Cancer Therapy

The Pathogenesis of Therapy-Related Myeloid Neoplasms from TP53 -Mutant Clonal Hematopoiesis

A New t(7;9)(p12;q34) Involving NOTCH1 and IKZF1 in Pediatric T-Cell Lymphoblastic Lymphoma

Association of unbalanced translocation der(1;7) with germline GATA2 mutations

Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia

Somatic Genetic and Epigenetic Architecture of Myelodysplastic Syndromes Arising from GATA2 Deficiency

Double hit, triple hit—look for it

Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment

The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia

The Recurrent SET-NUP214 Fusion as a New HOXA Activation Mechanism in Pediatric T-Cell Acute Lymphoblastic Leukemia.

Large Scale Copy Number Variation Upregulates the Expression of MYB in Human T-ALL.

Changes in the Hierarchy of Risk Factors with Older Age in De-Novo Acute Myeloid Leukemia (AML).

Intensification of Induction by High-Dose AraC and Outcome in Older Patients with De-Novo Acute Myeloid Leukemia (AML) and Subsets.

Double Induction Containing Two Courses Versus One Course of High- Dose AraC/ Mitoxantrone (HAM) and Autologous Stem Cell Transplantation Versus Prolonged Maintenance for Acute Myeloid Leukemia (AML).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only